SBIR Funding Opportunities

FOA#Topic/TitleBudgetDeadline
RFA-OD-20-020Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)$1.7 M for Ph IIDue Dates: 9/18/2020 (opens 8/30/2020)
RFA-OD-20-021Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) 256k + 1.7MSeptember 18, 2020
75N91020R00043National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Phase 0 Concept Award Program – Fiscal Year 2021
PAR-20-128SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed)$250 – $300KStandard SBIR dates
PAR-20-129SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)varies by ICStandard SBIR dates
PAR-20-130SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)varies by ICStandard SBIR dates
PA-20-260PHS 2020 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)$256,580 for Phase I, $1,710,531 for Phase IIStandard SBIR dates
PA-20-261PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)$256,580 for Phase I, $1,710,531 for Phase IIStandard SBIR dates
PA-20-262PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)$256,580 for Phase I, $1,710,531 for Phase IIStandard SBIR dates
PA-20-265PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)$256,580 for Phase I, $1,710,531 for Phase IIStandard SBIR dates
PA-20-244Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (SBIR) (R43/R44 Clinical Trial Not Allowed)$252,131 for Phase I, $1,680,879 for Phase IISeptember 4,2020
RFA-AG-21-026Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (SBIR U44 Clinical Trial Not Allowed$252,131 for Phase I, $1,680,879 for Phase IINovember 10, 2020
RFA-AG-21-025Development of Cost-Effective and Customizable Training and Education Platforms for AD/ADRD Caregivers that Focus on Addressing Financial Management and Legal Planning (R43/R44 Clinical Trial Not Allowed)$300 K Ph. 1, $1 M per year Ph IINovember 12, 2020
NOT-MH-20-013Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment
NOT-MH-20-020Notice of Special Interest: Stigma or Other Social Determinants of Health (SDOH) in HIV Prevention and Treatment
NOT-MH-20-023Notice of Special Interest (NOSI): Strengthening the HIV Care Continuum
NOT-MH-20-024Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
NOT-MH-20-035Notice of Special Interest: Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults
PAR-18-801Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 – Clinical Trial Optional)$300 K Phase I, $2 M Ph IIStandard Dates
NOT-AI-20-031Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) April 5, 2020-April 5, 2021
PAR-20-109Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed)Standard Phase I, II budgetsStandard SBIR/STTR dates
PAR-20-098Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed)Standard Phase I, II budgetsStandard SBIR/STTR dates
PA-20-025Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)Standard NIH STTR BudgetsApril 6, 2020 until Jan 6, 2023
PA-20-047Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed)Standard NIH STTR BudgetsApril 6, 2020 until Jan 6, 2023
FOA# Topic/Title Budget Deadline
NSF 20-546 Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 $256 ASAP
NSF 20-545 SBIR Phase II $1 M Feb 14-Dec. 3, 2020
NSF 20-546 STTR Phase II $1 M Feb 14-Dec. 3, 2020
FOA# Topic/Title Budget Deadline
DE-FOA-0002359 DOE Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) $200-250 K October 19, 2020
DOE SBIR/STTR Programs Phase I $200-250 K Ph I, $1.1 M – $1.6 M Ph II LOI August 31, 2020
FOA# Topic/Title Budget Deadline
Small Business Innovation Research Program – Phase I $106,500 October 22, 2020
USDA-NIFA-SBIR-006790 Small Business Innovation Research Program – Phase I $100K October 1, 2020
Tab Con
FOA# Topic/Title Budget Deadline
DoD DARPA SBIR/STTR $250 K December 31, 2020